Pfizer Builds on the Genedata Biopharma E2E Workflow Platform
After conducting a thorough market evaluation to identify an off-the-shelf enterprise system for large-molecule discovery, Pfizer implemented Genedata Biologics as their central repository for their biologics discovery data, including screening, molecular biology, engineering, expression, purification, and analytics.
MorphoSys Accelerates Antibody R&D with Genedata Biologics
After a formal selection process, MorphoSys adopted Genedata Biologics as their enterprise workflow platform because Genedata Biologics is the only off-the-shelf platform uniquely built for biopharmaceutical R&D.
Immatics Digitalizes CGT Discovery with Genedata Biologics
Leveraging Genedata’s out-of-the-box functionality, Immatics is streamlining CGT processes and increasing R&D efficiency. Genedata's scientific consultants also helped to configure Immatics-specific CGT workflows and integrate laboratory instruments so rollout of the platform was straightforward – and fast.
"Our collaboration with Genedata to develop a biologics data platform has been very successful. A commercial data management solution such as this has been sorely lacking in protein therapeutics."
Flexible Business Model Works for SMEs
"Thanks to Genedata’s flexible business model, we are able to take advantage of Genedata’s unique technology under terms that work well for a company of our size."
Central Registration & Data Management Platform
"Genedata seamlessly integrates into an existing research informatics environment and supports the full process through automation, standardization, and integration."
Flexible Architecture for Proprietary Configuration
“One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.”
Genedata Enables Data-Informed Decisions
“We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types across Genmab’s discovery and clinical workflows."
No Customization Needed Due to Built-in Business Logic
“We chose Genedata Biologics because its built-in business logic avoids costly software customization and it’s a proven off-the-shelf-product that can be implemented quickly and replace our current processes.”
“We appreciate Genedata Biologics’ flexible business model, which made it possible for a company of our size to adopt a market-leading platform solution.”
Genedata Accelerates Antibody Discovery at BI
"We undertook a thorough selection process to find the best antibody workflow platform and Genedata Biologics was the obvious choice."
Genedata Provides Backbone System
“Genedata Biologics was the clear choice as a backbone system to support the full diversity of our complex and rapidly evolving antibody discovery processes in the US and the UK.”
TCR Information Centrally Stored in Genedata
“Genedata Biologics gives all our R&D groups a central place to record and access TCR-related information in real time, along the end-to-end workflow."
Hard-to-Drug Targets Handled by Genedata
"The Genedata solution is now an integral part of our R&D infrastructure, supporting our efforts to develop novel biopharmaceuticals for hard-to-drug therapeutic targets.”
Orion Chooses Open & Scalable System
"Collaborating with CROs is a key part of our strategy, so we require an open and scalable system able to capture and integrate all data generated by our CRO network."
Mission-Critical Data Centrally Stored in Genedata
“We are rapidly expanding our biotherapeutic R&D activities and needed a scalable, flexible platform that we could quickly and easily implement. We chose Genedata Biologics as it is the only out-of-the-box platform on the market dedicated to large-molecule R&D.”
Scalable Backbone System Supports ADC Discovery
"Genedata Biologics is a key component of our growth plans in the immuno-oncology and next-generation ADC space. Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process—right through from the immunization of transgenic mice, to lead selection, molecular modification and final candidate assessments.”
Immunotherapy Discovery Programs Scaled Up
“Genedata Biologics provides a flexible architecture and includes built-in biopharma domain knowledge, which can handle our proprietary bispecific antibody discovery processes. We believe Genedata Biologics will help us to accelerate the discovery of the next generation of immuno-oncology therapeutics.”
Streamlining Operations & Increasing Throughput
“We made a decision early on to use Genedata Biologics as MorphoSys’ workflow backbone to accelerate our drug discovery efforts and have watched as Genedata Biologics has become the global industry standard for biopharma discovery organizations."